In the search to lower out-of-pocket costs for prescription drugs, consumers will encounter a number of different coupons, discounts and assistance programs available to them. They don't all work the ...

One of the most powerful components of the Affordable Care Act (ACA) was the mandate that nonprofit hospitals provide an income-based financial assistance program. But 10 years after the passage of ...

On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...

Pharmaceutical companies are taking a lot of reflected heat in the uproar over the 5,000% price hike for a drug needed by AIDS patients. But so far, the industry’s method of making sure that ...

Gilead’s U.S. Advancing Access ® patient assistance program was developed in conjunction with feedback from advocates in the HIV community. The program utilizes a rapid and simple process that ensures ...

When Beth Waldron got a letter from her health insurance provider last year that her blood thinner Eliquis would no longer be covered, she faced two options: Change to another medication that could ...

Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study One potential solution to ease the ...

Atlas Health taps into financial assistance programs for patients to help hospitals get paid. AI connects the money, patients and health systems. At any given time, there are more than 20,000 ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed and Health Law Scan, focusing on issues impacting the rare disease community.

Many organizations help patients pay for cancer treatment, medication, and other expenses. Fred Hutch Cancer Center offers financial assistance to patients based on family need. Low-income patients ...

Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting ...

Imatinib was the first targeted therapy approved for the treatment of cancer. With its approval, it was immediately clear to Novartis that this breakthrough therapy would require an innovative ...